|
|
||||||||
The Annals of Thoracic Surgery, Vol 58, 1031-1035, Copyright © 1994 by The Society of Thoracic Surgeons
M Tonz, LK von Segesser, J Schilling, TF Luscher, G Noll, B Leskosek and MI Turina
We examined the effectiveness of inhaled nitric oxide (NO) as a selective
pulmonary vasodilator in acute pulmonary hypertension in an in vivo canine
model with fixed cardiac output. In 5 dogs, total right heart bypass was
instituted, and pulmonary hypertension was induced by infusion of the
thromboxane analogue U-46619. During U-46619 infusion, NO was administered
at 10 and 40 ppm for 5 minutes followed by breathing of the oxygen mixture
without NO. Pump flow was held constant during the experiment. Infusion of
the thromboxane analogue resulted in an increase in pulmonary vascular
resistance and systemic vascular resistance from 147 +/- 83 to 740 +/- 126
dyne.s.cm-5 and from 1,720 +/- 113 to 2,407 +/- 232 dyne.s.cm-5,
respectively. During inhalation of 10 ppm NO, pulmonary vascular resistance
significantly decreased to 613 +/- 55 dyne.s.cm-5 (p < 0.05) and further
decreased to 527 +/- 163 dyne.s.cm-5 with 40 ppm NO inhalation (p <
0.05). Systemic vascular resistance did not change during NO treatment
(2,300 +/- 70 dyne.s.cm-5 during 40 ppm NO). There was no increase in
intrapulmonary shunting or methemoglobin levels during NO inhalation. In
this setting, with a constant cardiac output throughout the experiment, NO
acted as a selective pulmonary vasodilator without altering systemic
vascular resistance. However, induced pulmonary vasoconstriction was only
partially reversed by NO inhalation.
ARTICLES
Treatment of acute pulmonary hypertension with inhaled nitric oxide
Clinic for Cardiovascular Surgery, University Hospital, Zurich, Switzerland.
This article has been cited by other articles:
![]() |
F Urdaneta, E. Lobato, T Beaver, J. Muehlschlegel, D. Kirby, C Klodell, and A Sidi Treating pulmonary hypertension post cardiopulmonary bypass in pigs: milrinone vs. sildenafil analog Perfusion, March 1, 2008; 23(2): 117 - 125. [Abstract] [PDF] |
||||
![]() |
E. B. Lobato, T. Beaver, J. Muehlschlegel, D. S. Kirby, C. Klodell, and A. Sidi Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension Br. J. Anaesth., March 1, 2006; 96(3): 317 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Urdaneta, J. L. Willert, T. Beaver, B. Naik, D. S. Kirby, and E. B. Lobato Effects of a New Phosphodiesterase Enzyme Type V Inhibitor (UK 343-664) Versus Milrinone in a Porcine Model of Acute Pulmonary Hypertension Ann. Thorac. Surg., October 1, 2004; 78(4): 1433 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Bonnell, F. Urdaneta, D. S. Kirby, N. R. Valdez, T. M. Beaver, and E. B. Lobato Effects of sildenafil analogue UK 343-664 on a porcine model of acute pulmonary hypertension Ann. Thorac. Surg., January 1, 2004; 77(1): 238 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Corno, P. Tozzi, C. Y. Genton, and L. K. von Segesser Surgically induced unilateral pulmonary hypertension: time-related analysis of a new experimental model Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 513 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. von Segesser Cardiopulmonary support and extracorporeal membrane oxygenation for cardiac assist Ann. Thorac. Surg., August 1, 1999; 68(2): 672 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonz, O. N. Krogmann, O. M. Hess, B. Leskosek, T. Mihaljevic, L. K. von Segesser, and M. I. Turina Effect of Intermittent Warm Blood Cardioplegia on Functional Recovery After Prolonged Cardiac Arrest Ann. Thorac. Surg., October 1, 1996; 62(4): 1146 - 1151. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |